BIOLEGEND UK LIMITEDActive

Company number 07167526Private limited companyIncorporated 2010

Key figures

£8,373,160+11.9%
Net assets 2024
+9.3%
Average annual growth 2020–2024
02.5 m5 m7.5 m10 m20202021202220232024

BIOLEGEND UK LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m15 m20202021202220232024
Filed accounts2020–2024
20202021202220232024
Turnover15,483,67819,656,680———
Profit for the year677,703462,173466,934694,851887,587
Cash at bank and in hand5,951,6297,437,4643,422,1552,307,5235,714,984
Total assets13,416,62014,640,26513,311,5369,707,98313,425,545
Total liabilities7,593,5118,340,7006,529,5202,234,564—
Net assets / total equity5,861,6156,323,7886,790,7227,485,5738,373,160
Average number of employees252930350

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: BIOLEGEND UK LIMITED

Company

BIOLEGEND UK LIMITED is a private limited company registered with Companies House under company number 07167526. It was incorporated on 24 Feb 2010. Its status is active. The registered office is in London (NW5). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Profit for the year was £887,587. Net assets were £8,373,160, up 11.9% on the previous year. Cash at bank and in hand was £5,714,984. The company had an average of 0 employees. Figures are available for 5 financial years (2020–2024).

Control and charges

One person with significant control is registered. 1 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 24 Feb 2027.